Indications for Sleeve Gastrectomy-Is It Worth Waiting for Comorbidities to Develop?

Area of Science:

• Bariatric surgery
• Metabolic and endocrine disorders
• Obesity medicine

Background:

• Morbid obesity is linked to a higher incidence of serious health conditions, including heart disease, diabetes mellitus, and restrictive lung disease.
• Sleeve gastrectomy is a common bariatric procedure for weight management.

Purpose of the Study:

• To evaluate the efficacy of gastric sleeve surgery in weight loss and comorbidity resolution across different body mass index (BMI) categories.
• To assess the impact of early surgical intervention on patient quality of life and healthcare expenditure.

Main Methods:

• Patients were stratified into three BMI groups (30-34.9, 35-39.9, and >40 kg/m²).
• Preoperative assessments included cardiac ultrasound, respiratory function tests, and comorbidity evaluation.
• One-year follow-up compared weight loss rates and comorbidity status post-surgery.

Main Results:

• Gastric sleeve surgery demonstrated success in weight reduction across all BMI groups.
• No significant differences were observed in cardiac or respiratory function tests, aside from mild lipid level increases.
• Hypertension was the most prevalent preoperative comorbidity.

Conclusions:

• Early gastric sleeve surgery in younger patients with morbid obesity, even without severe comorbidities, leads to significant health improvements and enhanced quality of life.
• Performing bariatric surgery at a younger age reduces perioperative risks and lowers long-term healthcare costs by preventing comorbidity development.
• The study advocates for considering surgical intervention earlier, before the onset of multiple comorbidities, to maximize patient benefits.